Another study suggested that the combination of MLN8237 and cisplatin in cisplatin-resistant NSCLC cell lines led to decreased cell viability and increased apoptosis, as determined by Annexin V staining [23]. The gene discussed is ANXA5; the disease is non-small cell lung carcinoma.